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This study investigates the adhesion capacity of a polyglycolic acid- (PGA-) hyaluronan scaffold with a structural modification
based on a planar polymer (PM) surface in a cadaver cartilage defect model. Two cadaver specimens were used to serially test
multiple chondral matrices. In a cadaver hipmodel, cell free polymer-based cartilage implants with a planar bioinspired PM surface
(PGA-PM-scaffolds) were implanted arthroscopically on 10mm× 15mm full-thickness femoral hip cartilage lesions. Unprocessed
cartilage implants without a bioinspired PM surface were used as control group.The cartilage implants were fixed without and with
the use of fibrin glue on femoral hip cartilage defects. After 50movement cycles and removal of the distraction, a rearthroscopy was
performed to assess the outline attachment and integrity of the scaffold. The fixation techniques without and with fibrin fixation
showed marginal differences for outline attachment, area coverage, scaffold integrity, and endpoint fixation after 50 cycles. The
PGA-PM-scaffolds with fibrin fixation achieved a higher score in terms of the attachment, integrity, and endpoint fixation than the
PGA-scaffold on the cartilage defect. Relating to the outline attachment, area coverage, scaffold integrity, and endpoint fixation,
the fixation with PGA-PM-scaffolds accomplished significantly better results compared to the PGA-scaffolds (𝑃 = 0.03752, 𝑃 =
0.03078, 𝑃 = 0.00512, 𝑃 = 0.00512). PGA-PM-scaffolds demonstrate increased observed initial fixation strength in cadaver femoral
head defects relative to PGA-scaffold, particularly when fibrin glue is used for fixation.
1. Introduction
In the regenerative cartilage surgery, many surgical tech-
niques were developed for coating focal articular carti-
lage defects. Current available surgical cartilage treatments
include lavage and debridement, subchondral penetration
procedures (microfracture technique, drilling, or abrasion
chondroplasty), autogenous osteochondral transplantation
(AOT), and autologous chondrocyte implantation (ACI)with
or without using a scaffold [1–7].
As a single-stage procedure, the most used treatment
of focal cartilage defects represents the microfracture (Mfx)
technique in which a penetration of the subchondral bone
layer is performed with subsequent effluent of progenitor
cells from the bone marrow into the articular cartilage lesion
[1, 2, 8]. The progenitor cells are similar to chondrocytes but
form a fibrocartilaginous tissue which is mechanically and
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Scaffold-assisted single-step techniques were developed
to enhance cartilage tissue regeneration by the combination
of theMfxwith a biomaterial. By combination of theMfxwith
a scaffold, the mesenchymal stem cells (MSCs) are attracted
into the biomaterial and the chondrogenic differentiation
of the MSCs to cartilage repair tissue is better assured
such as the sole application of the Mfx [10, 11]. However,
the fibrin clot is not mechanically stable, so the implanted
scaffold enhances the mechanical stability in the defect zone
additionally [12]. The biomaterial serves as a biostructure
for cell attachment of the MSCs [13]. Different matrices are
currently available for surgical cartilage repair like scaffolds
with porcine collagen I/III membrane [14, 15]. Another
scaffolding for cartilage repair is a cell free matrix composed
of an absorbable nonwoven polyglycolic acid (PGA) textile
combined with hyaluronic acid (HA) [16, 17].Themechanical
stability of the matrix allows for easy treatment and safe
fixation in the cartilage lesion by fibrin sealant, cartilage, or
transosseous suture, or by resorbable pins [18, 19]. However,
the arthroscopic pin insertion for fixation of the scaffold
represents a challenge during arthroscopic cartilage repair.
An incorrect placed pin can release cartilage damage of the
articular opposite side [20].
The importance of the primary fixation of the scaffolds is
common, but there is no study available which examines the
influence of a structural modification of the scaffold surface
in order to achieve a higher adhesion ability [21].
Here we compare and quantify the primary fixation
stability of a commonly used scaffold for cartilage repair
attached by a planar bioinspired polymer (PM) surface in a
cadaver hip model. The aim of our experimental study was
that the arthroscopic implantation of a cell free polymer-
based scaffold with a structure derived from tree-frog foot-
pads was more stabile compared to an unprocessed scaffold.
2. Materials and Methods
2.1. Testing Protocol. The study was approved by the local
ethical committee of the Ruhr-University Bochum (regis-
tration number 4611-13). The surgery was performed by
two orthopaedic surgeons experienced in hip arthroscopy
(Matthias Lahner, Christian Duif). The fluoroscope was
placed diagonally across the table (Philips, Hamburg, Ger-
many). In this study, two right human cadaver hips were
arranged for hip arthroscopy in a supine position demon-
strated in Figure 1. Arthroscopy for the central joint com-
partment was performed with distraction. The ventral portal
was created under fluoroscope. The hip capsule was widened
through a 1.5mm guide wire with sequential telescoping
4mm and 6mm portal dilators (Arthrex, Naples, FL, USA).
After advancing a 5.5mm fenestrated metal cannula into
the joint, an arthroscopic evaluation was performed with
a 70∘ 4mm scope (Arthrex). A second instrumentation
portal approachwas establishedwith a 14-gauge needle under
arthroscopic and fluoroscopic view. The hip capsule was
penetrated with a 4mmdilator and an 8mm × 4 cm pass port
button cannula (Arthrex) which was positioned to create a
stable portal. By using a bone cutter (Arthrex), a 10 × 15mm
Figure 1: Experimental setup with arthroscopy and fluoroscopy
equipment.
full-thickness cartilage defect was created in the zone 2 of the
femoral head (hip 1 and 2) described by Ilizaliturri et al. [22].
Then different scaffolds were placed into the defect, either
a PGA-hyaluronan scaffold without structural modification
(Figure 2) or a bioinspired PGA-PM-scaffold (Figure 3). Both
groups were implanted with or without fibrin glue (Evicel,
Omrix Biopharmaceuticals NV, Diegem, Belgium). Both
cadavers had all four treatments.
2.2. Testing Groups. The resorbable PGA-hyaluronan scaf-
fold (BioTissue Technologies GmbH, Freiburg, Germany) of
10mm× 15mm× 1.1mmwas impregnatedwith an embossing
stamp. The embossing stamp consisted of a thermoplastic
polymer (PM) surface composed of acrylnitrile butadiene
styrene (ABS).ThePMwas designed of amoulding formwith
computer-aided design (CAD) software from a 3D printer
(Dimension BST, Stratasys, Eden Prairie, USA). The PGA-
hyaluronan scaffold was loaded with the PM embossing
stamp with a defined 4 kilo force for about 20 minutes
in a laboratory-type drying cabinet at 80∘C. The PGA-PM-
scaffold was produced only for experimental use. For the
fixation, the scaffold was placed directly onto the defect of the
subchondral bone without additional material.
2.3. Arthroscopic Implantation. After evacuating the saline
solution, the scaffold was implanted by the use of a tissue
grasper and simply released above the full-thickness cartilage
defect. By using a tissue elevator, the scaffolds were shaped
into the defect to reach a 100% filling of the defect. Before
fixation of the scaffoldwith fibrin glue, we used an application
device with a 35 cm tip (Evicel) through the instrumentation
portal. After removing the distraction, 50 cycles of flexion
(90∘) and extension (10∘) were performed by moving the
leg manually. The cycles were conducted by an independent
third-party-assistant that was blinded to the assessment of
the measurements.Then, the hip joint was refilled with saline
solution and the defect area with the implanted scaffold
was inspected (Figures 4 and 5). After the implantation
of scaffold, the matrix was completely removed and the
fibrin glue was eliminated by the shaver. All hip cadavers
underwent the presented motion protocol with two fixation
techniques tested on each hip. The outline attachment and
the percentage of defect-covering scaffold were noticed as
well as the integrity of the scaffold itself. The endpoint
fixation strength was manually tested by a palpating hook.






























Figure 3: PGA-scaffold with polymer (PM) surface (a) and confocal stereomicroscopic picture of the scaffold before fixation (b).
Figure 4: Implantation of the PGA-scaffold on a full-thickness
femoral hip cartilage defect.The implantwas used to cover the defect
and fixed by a fibrin glue.
The properties of the scaffold were directly evaluated by two
orthopedic surgeons. All scaffolds were photographed at each
rearthroscopy and reviewed by the third collaborator who did
not participate in the initial surgery. We performed therefore
three measurements per fixation. A consensus of all three
evaluators was taken as the end result.
Figure 5: Implantation of the PGA-scaffold modified with a planar
PM surface. The implant was used to cover the defect and fixed by a
fibrin glue.
2.4. Classification of Scaffold Evaluation. To classify the
differences concerning adhesion and integrity between the
tested scaffolds, we modified the scoring system developed
by Bekkers et al. [23]. Outline attachment, area coverage,
scaffold integrity, and endpoint fixation were assessed and
a corresponding score was determined in a 5-point scale
(Table 1).
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Table 1: Modified criteria for the scaffold evaluation described by Bekkers et al. [23]. The assigned points are given in brackets.
Outline
attachment∗ Area coverage Scaffold integrity
∗∗ Endpoint fixation∗∗∗
Unchanged (5) Unchanged (5) Unchanged (5) Cannot be detached (5)
<25% (4) Shape deformities without structuraldamage (4)
Shape deformities or minor fissures that
are unrelated to fixation (4) Detached with intensive pull (4)
25–50% (3) Fissures or cracks without importantsubstances loss (3)
Minor fissures or cracks close to the
fixation site (3) Detached with minor pull (3)
50–75% (2) <25% of scaffold lost (2) Fissures or cracks endangering thefixation of the scaffold (2) Detached with slight touch (2)
75–100% (1) 25–50% of scaffold lost (1)
Fissures or cracks endangering the
fixation with surrounding scaffold
disorganization (1)
Partial detachment (1)
100% (0) >50% of scaffold lost (0)
Fissures or cracks endangering the
fixation with generalized scaffold
disorganization (0)
Total detachment (0)
∗% of full circumference that has lost contact with the surrounding cartilage rim.
∗∗% of total cartilage defect that is covered by scaffold.
∗∗∗The endpoint fixation was tested by a palpation hock manipulation after the motion cycles were completed.
Table 2: Results of two scaffold fixation techniques on two human cadavers after 50 cycles of continuous motion.
Material Fixationtechnique
Outline attachment
50 cycles average score
(±standard deviation)
Area coverage
50 cycles average score
(±standard deviation)
Scaffold integrity
50 cycles average score
(±standard deviation)
Endpoint fixation
50 cycles average score
(±standard deviation)
PGA-scaffold Unfixed 1.0 (±0) 1.5 (±0.7) 1.0 (±0) 0.5 (±0.7)
PGA-PM-scaffold Unfixed 2.0 (±0)∗ 2.0 (±0) 1.0 (±0) 2.0 (±0)∗
PGA-scaffold Fixed withfibrin glue 2.5 (±0.7) 2.5 (±0.7) 3.0 (±0.7) 2.0 (±0.0)
PGA-PM-scaffold Fixed withfibrin glue 3.5 (±0.7)
∗ 3.5 (±0.7)∗ 4.0 (±0.7)∗ 3.0 (±0.0)∗
Average per scoring item for the scaffold fixation techniques after 50 cycles (∗𝑃 < 0.05).
2.5. Statistical Analysis. For each individual fixation tech-
nique, the average scores and standard deviations per scoring
item were calculated after 50 motion cycles. The arithmetic
mean value and the SDwere calculated for the variables above
and measured with Microsoft Excel (Microsoft, Redmond,
WA, USA). The values were recorded in IBM SPSS Statistics
22 (PASW 22, SPSS Inc., Chicago, IL, USA). Mean values of
each set were performed using Mann-Whitney U test with
level of significance defined at ∗𝑃 < 0.05.
3. Results
All the fixation techniques were feasible through the initial
incision.None of the specimens showedmacroscopic damage
at the opposing articular cartilage surface. We compared the
unfixed PGA-scaffold versus the unfixed PGA-PM-scaffold
plus the PGA-scaffold with fibrin glue versus the PGA-PM-
scaffold with fibrin glue. The results of the scaffold fixation
are shown in Table 2. Concerning the scaffolds fixed with fib-
rin glue, the fixation with PGA-PM-scaffolds accomplished
significantly better results compared to the PGA-scaffolds
relating to the outline attachment, area coverage, scaffold
integrity, and endpoint fixation (𝑃 = 0.03752, 𝑃 = 0.03078,
𝑃 = 0.00512, 𝑃 = 0.00512). Concerning the outline
attachment and endpoint fixation, lower statistically signif-
icant scores were found for the unfixed PGA-PM-scaffold
compared to the PGA-scaffold (𝑃 = 0.02034, 𝑃 = 0.01314).
With regard to the area coverage and scaffold integrity, no
statistical difference was observed between the unfixed PGA-
scaffold and the unfixed PGA-PM-scaffold after 50 cycles
(𝑃 = 0.17384 𝑃 = 0.06576). Closer examination showed
an incomplete detachment of the PGA-scaffold without fibrin
glue to a complete attachment of the PGA-PM-scaffold with
adhesive fixation. However, no rupture of the scaffold fiber
was observed during arthroscopic implantation. Relating to
the scaffold integrity, the PGA-PM-scaffold with fibrin glue
achieved the best result after themotion cycles.Thefibrin glue
fixation with PGA-PM-scaffolds provided the best scaffold
integrity as compared to scaffolds without adhesive fixation
after 50 cycles. The endpoint fixation strength of the scaffold
was highest in the PGA-PM-scaffold fixed with fibrin glue.
Table 3 shows a summary concerning the advantages and
disadvantages as well as the pros and cons of the clinical
procedure of the PGA-PM-scaffolds.
4. Discussion
In the present study, we assessed the primary arthroscopic
fixation stability of scaffold-based tissue-engineered implants
BioMed Research International 5
Table 3: Summary of the clinical procedure of the PGA-PM-scaffolds.
Advantages Disadvantages Pros Cons
Single-stage procedure
Suitable for medium chondral defects (2–4 cm2)
Low operative cost
Demanding arthroscopic technique








of full-thickness cartilage defects in cadaver hips to simulate
the adhesion properties. Regarding the fixation, we showed
that the adherence on the cartilage defect was higher with the
PGA-PM-scaffold than with the unmodified PGA-scaffold.
These results were collected in experimental settings with
high similarity to the intended application. They confirm the
initial assessment from the development process.
This study was limited by the reduced number of
implanted scaffolds and the lack of power analysis. Another
limitation of our study was that we did not apply static
uniaxial tensile tests on in situ cadaver legs; thus the transfer
of the findings to a clinical setting is difficult. However, we did
not accomplish intra-articular pressure measuring, but it can
be assumed that the anatomical precondition of the hip joint
with additional burden during motion generated a shearing
force on the scaffold,which is similar to the in vivo conditions.
This shear force will partially be conveyed directly by friction
with the opposing cartilage andpartially by the intra-articular
remaining saline solution. Further biomechanical studies
are needed to prove whether a slightly submerged implant
could protect it from the friction in vivo, although in one
rabbit model trial, it was demonstrated that submergedmetal
grafts in focal cartilage lesion deranged the integrity of the
articulating cartilage surfaces [24].
Bekkers et al. demonstrated the need for a compro-
mise between fixation stability and scaffold integrity [23].
Therefore, the primary adhesion of the implanted scaffold
without further fixation devices may help to eliminate this
discrepancy and improve results of fixation of the scaffold
which are implanted arthroscopically.
The present study examines for the first time different
arthroscopic fixation techniques of cartilage implants of the
hip joint in an experimental setup. It demonstrates that
bioinspired structural alterations of scaffolds may support
arthroscopic application significantly. Since the role of hip
arthroscopy and consequently the number of surgeons who
apply this technique have significantly increased in the recent
years our study presents an important impulse towards easier
procedures and subsequently broader clinical application
[25].
Furthermore, a stickier scaffoldmay allow cartilage repair
as a simple one step procedure when extended fixation tech-
niques, for example, transosseous fixation or biodegradable
pin fixation, are impossible due to tight anatomical conditions
or operational circumstances like the hip joint.
The presented technique is a single-step procedure. In a
clinical study, Fontana et al. showed that the arthroscopic
autologous chondrocyte transplantation (ACT) is superior
to arthroscopic debridement of hip chondral defects [26].
However, ACT requires a two-stage operation which rep-
resents a burden for the patient. Combining our technique
with an improved cartilage implant with Mfx, MSCs are
attracted to immigrate into the bioinspired PM-scaffold.
Thereby, bioinspired PM-scaffold depicts a matrix for the
condrogenic differentiation of the MSCs.
In an arthroscopic hip study, Mancini and Fontana
compared the clinical outcome of the arthroscopic matrix-
induced autologous chondrocyte implant (MACI) with the
autologous matrix-induced chondrogenesis (AMIC) tech-
niques which is matchable to our technique [27].The authors
showed that the AMIC technique as a single-stage procedure
is a valid procedure for improvement in patients concerned
by chondral defects.
5. Conclusions
This study focuses on the arthroscopic application of
enhanced cartilage implants on femoral hip cartilage lesions.
Although this essential aspect is difficult to objectify, the
authors of this paper underline the improved implanta-
tion conditions by using the PGA-PM-scaffold and eagerly
anticipate the experiences of other arthroscopic hip sur-
geons. PGA-PM-scaffolds demonstrate increased observed
initial fixation strength in cadaver femoral head defects
relative to PGA-scaffold, particularly when fibrin glue is used
for fixation. Further investigations including biomechanical
adhesion analysis and studies with a greater number of cases
are necessary.
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